Abstract: OBJECTIVES: We aimed to assess the predictive value of the SYNTAX score (SXscore) for major adverse cardiac events in the all-comers population of the LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. BACKGROUND: The SXscore has been shown to be an effective predictor of clinical outcomes in patients with multivessel disease undergoing percutaneous coronary intervention. METHODS: The SXscore was prospectively collected in 1,397 of the 1,707 patients enrolled in the LEADERS trial (patients after surgical revascularization were excluded). Post hoc analysis was performed by stratifying clinical outcomes at 1-year follow-up, according to 1 of 3 SXscore tertiles. RESULTS: The 1,397 patients were divided into tertiles based on the SXscore in the following fashion: SXscore<or=8 (SXlow) (n=464), SXscore>8 and <or=16 (SXmid) (n=472), and SXscore>16 (SXhigh) (n=461). At 1-year follow-up, there was a significantly lower number of patients with major cardiac event-free survival in the highest tertile of SXscore (SXlow=92.2%, SXmid=91.1%, and SXhigh=84.6%; p<0.001). Death occurred in 1.5% of SXlow patients, 2.1% of SXmid patients, and 5.6% of SXhigh patients (hazard ratio [HR]: 1.97, 95% confidence interval [CI]: 1.29 to 3.01; p=0.002). The myocardial infarction rate tended to be higher in the SXhigh group. Target vessel revascularization was 11.3% in the SXhigh group compared with 6.3% and 7.8% in the SXlow and SXmid groups, respectively (HR: 1.38, 95% CI: 1.1 to 1.75; p=0.006). Composite of cardiac death, myocardial infarction, and clinically indicated target vessel revascularization was 7.8%, 8.9%, and 15.4% in the SXlow, SXmid, and SXhigh groups, respectively (HR: 1.47, 95% CI: 1.19 to 1.81; p<0.001). CONCLUSIONS: The SXscore, when applied to an all-comers patient population treated with drug-eluting stents, may allow prospective risk stratification of patients undergoing percutaneous coronary intervention. ( Value of the SYNTAX score (SX) for risk assessment in the "all-comers" population of the ra 
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Introduction:
The SYNTAX score (SXscore) is a comprehensive angiographic scoring system that is derived entirely from the coronary anatomy and lesion characteristics.(1-3) It was initially designed to quantify lesion complexity, however, it is also able to predict major adverse cardiac events (MACE) following percutaneous revascularization in patients with multivessel coronary artery disease(4-6) and/or left main disease. (7) More recent data indicates its ability to predict peripr intervent ocedural myocardial infarction (MI) in patients undergoing elective percutaneous coronary ion (PCI). (8) In this sub-study of the LEADERS trial (Limus Eluted from A Durable versus ERodable Stent coating), where the SXscore was collected prospectively in 1,397 "allcomer" patients, we assessed its prognostic value for MACE events at 1 year follow-up. hich was comparable to the 51% higher composite event rate among diabetics (p=0.022). Use 9 Stent thrombosis rates: The rate of definite stent thrombosis was 0.9%, 2.1% and 3.5% in the SXlow, SXmid and SXhigh, respectively and the ARTS-II study, which both demonstrated the good predictive value of the SXscore in patients with multivessel disease, with the highest tertile patients having significantly more MACE events during short(4,5) and long-term follow-up. (6) This study is the first to report the utility of the SXscore as a predictor of MACE, including cardiac death, in an "all-comers" population including patients with acute coronary syndromes. 
Conclusion:
This study demonstrates that the prognostic value of the SYNTAX score is valid for all patients w ith de novo coronary artery disease undergoing percutaneous revascularisation. 
